AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy

RecruitingNAAges 65 Years - anyAllChang Gung Memorial Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Gastric, biliary and pancreatic cancer are commonly malignancies from gastro- intestinal tract in Taiwan. Because lack of specific symptoms at presentation and effective screening methodology, majority of these patients are diagnosed with metastatic or unresectable disease. Palliative chemotherapy is the good standard of therapy for patients with unresectable gastric, biliary and pancreatic cancer with benefit of prolong survival time and improve quality of life. Although the benefit of palliative chemotherapy seems to be the same for elderly and young cancer patients in clinical study, elderly patients are less frequently treated with chemotherapy or treated with suboptimal dosage. Elderly patients do not receive palliative chemotherapy because concerns of elder age, comorbidity, poor performance, lack of social/economic support and worry about treatment toxicities. The increase in li

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients aged sixty-five or older with metastatic or unresectable gastric, biliary, and pancreatic cancer. * The patient must sign the informed consent form. * Estimated survival period of more than 3 months. * Conscious and able to communicate verbally or in writing, and willing to cooperate with invasive procedures. Exclusion Criteria: * Patients with cognitive impairment or unable to cooperate with the interventional procedures as determined by the clinical physician. * Patients receiving concurrent other anticancer treatments (radiation or surgery). * Patients with multiple types of cancer requiring simultaneous treatment. * Patients who have previously participated in this study during a prior chemotherapy regimen.
๐Ÿ’Š

What it tests

  • Frailty intervention measures
๐Ÿ“

Where

1 site
Chang Gung Memorial Hospital
Taoyuan, Taiwan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy